I'm hoping that this is part of an overalll strategy to make them either an aquisition target or at least to get a buy-in from a producer ( ie Kinross). This property acquisition plus some decent assay results could put Sage in a good position for one of these outcomes. If they haven't fully developed a plan to reach a specific endgame then they will find themselves very overstretched early next year.